Wednesday, July 8, 2026

Patent intelligence · US

US 10052467

Applicator for applying a fluid to a surface

granted A61KA61K31/568A61K9/0014
Status granted
Linked drugs 3
Pipeline programs 6
Years to expiry 12
Applicant portfolio 32
Patent details — US 10052467
Jurisdiction
US
Status
granted
Grant date
Aug 21, 2018
Expiration
Aug 16, 2038
Claims
19
CPC classes
A61K, A61K31/568, A61K9/0014
View on Google Patents ↗

Quick answer

US 10052467 (Applicator for applying a fluid to a surface) is held by AMNEAL PHARMACEUTICALS LLC. Status: granted. Granted Aug 21, 2018. Expires Aug 16, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
19
CPC classes
A61K, A61K31/568, A61K9/0014

More from AMNEAL PHARMACEUTICALS LLC

Related pharmaceutical patents in our USPTO index.

  1. US 12383522

    Baclofen formulations and methods of minimizing patient exposure to metabolite variations

    AMNEAL PHARMACEUTICALS LLC · Expires Aug 7, 2045

    granted
  2. US 12370163

    Levodopa dosing regimen

    AMNEAL PHARMACEUTICALS LLC · Expires Jul 24, 2045

    granted
  3. US 12303482

    Levodopa dosing regimen

    AMNEAL PHARMACEUTICALS LLC · Expires May 15, 2045

    granted
  4. US 12303481

    Levodopa dosing regimen

    AMNEAL PHARMACEUTICALS LLC · Expires May 15, 2045

    granted
  5. US 12295931

    Levodopa dosing regimen

    AMNEAL PHARMACEUTICALS LLC · Expires May 8, 2045

    granted
  6. US 12263149

    Levodopa dosing regimen

    AMNEAL PHARMACEUTICALS LLC · Expires Mar 27, 2045

    granted
  7. US 12263148

    Levodopa dosing regimen

    AMNEAL PHARMACEUTICALS LLC · Expires Mar 27, 2045

    granted
  8. US 12233166

    Extended release compositions comprising pyridostigmine

    Amneal Complex Products Research LLC · Expires Feb 20, 2045

    granted

Frequently asked questions

What is US patent 10052467?

US 10052467 (Applicator for applying a fluid to a surface) is held by AMNEAL PHARMACEUTICALS LLC. Status: granted. Granted Aug 21, 2018. Expires Aug 16, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 10052467?

AMNEAL PHARMACEUTICALS LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 32 pharmaceutical patents for this assignee.

When does US 10052467 expire?

Our index shows an expiration date of Aug 16, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.